Author(s):
Tejaswini G. Khonde, Sakshi P. Waikar, Nilakshi Dhoble, Nitin Padole, Pankaj Dhapke, Jagdish R. Baheti
Email(s):
tejukhonde57@gmail.com
DOI:
10.52711/2231-5659.2026.00001 
Address:
Tejaswini G. Khonde*, Sakshi P. Waikar, Nilakshi Dhoble, Nitin Padole, Pankaj Dhapke, Jagdish R. Baheti
Department of Pharmaceutics, Kamla Nehru College of Pharmacy, Butibori, RTMNU University, Nagpur.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2026
ABSTRACT:
Psoriasis is a chronic, immune-mediated skin disease marked by excessive keratinocyte proliferation, resulting in scaly, inflamed plaques. Topical corticosteroids are widely used but are limited by poor solubility, low skin permeability, and systemic side effects. This study aimed to develop and optimize a nanosuspension of Clobetasol-17-propionate for improved topical delivery. Nanosuspensions were prepared using the nanoprecipitation method and optimized via Box–Behnken design, with ß-cyclodextrin (ß-CD), sodium lauryl sulfate (SLS), and sonication time as independent variables. The optimized formulation (T7) demonstrated a particle size of 371.6nm, entrapment efficiency of 90.00%, and zeta potential of -34.21mV, indicating good physical stability. FTIR and DSC confirmed drug–excipient compatibility, while FE-SEM revealed spherical morphology. The formulation showed suitable pH (5.5), viscosity (856 Cps), and high drug content (96.00%).in-vitro diffusion studies confirmed controlled drug release, with 96.08% cumulative release in 240minutes. Stability studies over six months showed no significant changes in particle size or drug entrapment. the results suggest that the nanosuspension effectively enhances skin retention and controlled release of Clobetasol-17-propionate, making it a promising approach for the topical treatment of psoriasis.
Cite this article:
Tejaswini G. Khonde, Sakshi P. Waikar, Nilakshi Dhoble, Nitin Padole, Pankaj Dhapke, Jagdish R. Baheti. Design and Evaluation of Nanosuspension for improved Psoriasis Treatment. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(1):1-8. doi: 10.52711/2231-5659.2026.00001
Cite(Electronic):
Tejaswini G. Khonde, Sakshi P. Waikar, Nilakshi Dhoble, Nitin Padole, Pankaj Dhapke, Jagdish R. Baheti. Design and Evaluation of Nanosuspension for improved Psoriasis Treatment. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(1):1-8. doi: 10.52711/2231-5659.2026.00001 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2026-16-1-1
REFERENCES:
1. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. International Journal of Molecular Sciences. 2019 Mar 23; 20(6): 1475 Doi: https://doi.org/10.3390/ijms20061475.
2. Rajguru JP, Maya D, Kumar D, Suri P, Bhardwaj S, Patel ND. Update on psoriasis: A review. Journal of Family Medicine and Primary Care. 2020 Jan 1; 9(1): 20-24. Doi: 10.4103/jfmpc.jfmpc_689_19
3. Shah NV, Maheshwari RA, Sailor GU, Aundhia CJ, Chauhan SP, Javia AR. A Review on Etiology, Types and Treatment of Psoriasis. Pharmacology online. 2010; 1: 159-179. Doi: 10.4103/pc. pc_689_19
4. Gharge R, Phadatare S, Shinde S, Chogale E, Patil S, Pujare P. Psoriasis: causes, diagnosis and management. Small. 2021 Oct 15; 3: 4 Doi: 10.20959/wjpr202114-22238
5. Kolarsick PA, Kolarsick MA, Goodwin C. Anatomy and physiology of the skin. Journal of the Dermatology Nurses' Association. 2011 Jul 1; 3(4): 203-213. Doi: 10.1097/JDN.0b013e3182274a98
6. Yadav SK, Mishra MK, Tiwari A, Shukla A. Emulgel: A new approach for enhanced topical drug delivery. Int. J. Curr. Pharm. Res. 2016 Dec; 9(1): 15-19. Doi: http://dx.doi.org/10.22159/ijcpr.2017v9i1.16628
7. Pınar SG, Oktay AN, Karaküçük AE, Çelebi N. Formulation strategies of nanosuspensions for various administration routes. Pharmaceutics. 2023 May 17; 15(5): 1520. Doi: https://doi.org/10.3390/pharmaceutics15051520
8. Aldeeb MM, Wilar G, Suhandi C, Elamin KM, Wathoni N. Nanosuspension-based drug delivery systems for topical applications. International Journal of Nanomedicine. 2024 Dec 31: 825-844. Doi: https://doi.org/10.2147/IJN.S447429
9. Jadhav SP, Singh SK, Chawra HS. Review on Nanosuspension as a Novel Method for solubility and bioavailability enhancement of poorly soluble drugs. Adv Pharmacol Pharm. 2023; 11(2): 117-130. Doi: 10.13189/app.2023.110204.
10. Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, Filipe P. Mechanisms of action of topical corticosteroids in psoriasis. International Journal of Endocrinology. 2012; 2012(1):5610-5618doi: https://doi.org/10.1155/2012/561018
11. Vyas PR, Patel kj. Enhancement of solubility of itraconazole using novel liquid solid technique. Pharma Science Monitor. 2015 Apr 1; 6(2). Doi:10.47750/pnr.2022.13.S08.353
12. Yadav M, Aggarwal P, Yadav D, Singh A. Formulation and evaluation of clobetasol-17-propionate-loaded carboxymethyl chitosan nanoparticle. Asian J Pharm Clin Res. 2022; 15(9): 88-93. Doi: http://dx.doi.org/10.22159/ajpcr.2022v15i9.45743
13. Devi N, Kumar S, Rajan S, Gegoria J, Mahant S, Rao R. Development and validation of UV spectrophotometric method for quantitative estimation of clobetasol 17-propionate. Asian Journal of Chemistry and Pharmaceutical Sciences. 2016 Nov 21; 1(1): 36-40. Doi:10.26480/acmy.02.2022.89.94
14. Yadav M, Aggarwal P, Yadav D, Singh A. Formulation and evaluation of clobetasol-17-propionate-loaded carboxymethyl chitosan nanoparticle. Asian J Pharm Clin Res. 2022; 15(9): 88-93. Doi: http://dx.doi.org/10.22159/ajpcr.2022v15i9.45743
15. Sharma A, Guarvea K, Singh R. Pre-Formulation Profiling of Aceclofenac and Development of a Sensitive Analytical Technique for Its Assessment. Indian Drugs. 2021 Sep 1;58(9): 580.doi:10.53879/id.58.09.12975
16. Pore YV, Shinde VR, Rao JV. Physical stabilization of amorphous itraconazole in solid dispersions for improved dissolution profile. Journal of Applied Pharmaceutical Science. 2016 Oct 29;6(10):037-044. Doi:10.7324/JAPS.2016.601005
17. Dawood NM, Abdal-Hamid SN. Formulation and characterization of lafutidine nanosuspension for oral drug delivery system. Int J App Pharm. 2018; 10(2): 20-30. Doi: http://dx.doi.org/10.22159/ijap.2018v10i2.23075
18. Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension. International Journal of Pharmaceutics. 2015 Jan 30;478(2):540-552.Doi: https://doi.org/10.1016/j.ijpharm.2014.12.003
19. Abbas HK, Wais FM, Abood AN. Preparation and evaluation of ketoprofen nanosuspension using solvent evaporation technique. Iraqi Journal of Pharmaceutical Sciences. 2017 Dec 25: 41-55. Doi: https://doi.org/10.31351/vol26iss2pp41-55
20. Abbas AF, Ashoor JA, Mahmood HS. Formulation and Evaluation of Flucinolone Acetonide as nanosuspension for topical skin administration.
21. Ramesh Y, Sarayu B, Chandana GH, Neelima O, Sana S. Formulation and evaluation of lamivudine nanosuspension. J Drug Deliv Therap. 2021 Jul 2; 11(4-S): 71-77. Doi: http://dx.doi.org/10.22270/jddt.v11i4-S.4961
22. Sumathi R, Tamizharasi S, Sivakumar T. Formulation and evaluation of polymeric nanosuspension of naringenin. Int J App Pharm. 2017 Oct; 9(6): 60-70. Doi: http://dx.doi.org/10.22159/ijap.2017v9i6.21674
23. Parekh KK, Paun JS, Soniwala MM. Formulation and evaluation of nanosuspension to improve solubility and dissolution of diacerein. International Journal of Pharmaceutical Sciences and Research. 2017 Apr 1; 8(4): 1643. Doi:10.13040/IJPSR.0975-8232.8(4).1643-53